Navigation Links
DaVita Launches Minority Bank Initiative with $5 Million Investment in Underserved Communities Across the Country
Date:11/23/2009

Partnerships with Minority Banks in Washington D.C., New York, N.Y., Los Angeles, Calif. and Columbia, S.C. Intended to Spur Economic Growth and Revitalization

WASHINGTON, Nov. 23 /PRNewswire-USNewswire/ -- DaVita, the nation's leading provider of dialysis services, today announced a nationwide Minority Bank Initiative designed to create jobs and spur revitalization in minority communities across the country with investments in leading community and minority-owned banks. DaVita has donated $5 million through bank partnerships in Washington, DC, New York, N.Y., Los Angeles, Calif. and Columbia, S.C.

"DaVita is committed to developing business partner relationships that reflect our diverse base of patients and teammates," said Kent Thiry, DaVita CEO. "Through our Minority Bank Initiative, DaVita is supporting the revitalization of under-served neighborhoods it serves by helping banking institutions as well as minority-owned businesses to thrive."

DaVita is partnering with the following leading institutions in urban centers where it provides life-saving kidney care services to some of the approximately 114,000 patients it serves throughout the country:

  • Industrial Bank, Washington, D.C.: Industrial Bank is the oldest and largest minority commercial bank in the metropolitan Washington region;
  • Carver Federal Savings Bank, New York, N.Y.: Carver Bank is the largest African-American operated bank in the United States;
  • Broadway Bank, Los Angeles, Calif.: Broadway Bank serves the diverse ethnic markets of South Central and Mid-City Los Angeles, and specializes in inner-city community reinvestment.
  • South Carolina Community Bank, Columbia, S.C.: South Carolina Community Bank has been committed to building relationships and building communities since its inception in 1999.

These institutions deliver essential banking and financial services that have contributed greatly to the growth and development of under-served communities.

B. Doyle Mitchell, President and CEO of Industrial Bank of Washington, welcomed DaVita's generous investment which, he said, would enhance Industrial Bank's community-focused initiatives. "We look forward to a successful partnership with DaVita," said Mitchell. "Industrial Bank has a strong legacy of community involvement and economic development and our partnership with DaVita is a vital step toward our goal of helping our clients achieve their financial dreams."

Announcement of DaVita's investment is being made in conjunction with a series of community-based open houses where residents will be provided immediate assistance with free kidney health risk assessments and educated on the risk factors for kidney disease including high blood pressure, diabetes and obesity.

Each year, more than 100,000 Americans are diagnosed with End Stage Renal Disease (ESRD) -- or kidney failure -- and require dialysis or a kidney transplant in order to survive. Today, approximately 527,000 patients in the United States are living with kidney failure -- more than half of whom are minorities. Today residents of Washington, D.C.'s Anacostia neighborhood were screened for and educated on the leading risk factors for kidney failure.

The National Minority Bank Initiative was developed by DaVita to help the company participate in the revitalization of under-served communities. The partnership is designed to support efforts and outreach to minorities in communities served by both the minority-owned banks and DaVita.

Michael Grant, President of the National Bankers Association, a vital trade organization representing minority and women-owned financial institutions, lauded DaVita for its corporate responsibility and for its investment in under-served communities across the country. "DaVita's investment in minority communities will support the type of wealth-enhancing opportunities our members are striving to provide in the communities we serve," said Grant. "DaVita's generous investment will expand access to capital for minority banks' consumer and business patrons and clients."

DaVita(R) is a registered trademark of DaVita Inc. All other trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita has been recognized as the only FORTUNE 500(R) company on WorldBlu's annual List of Most Democratic Workplaces(TM). As of March 31, 2009, DaVita operated or provided administrative services at 1,475 outpatient dialysis facilities and acute units in approximately 700 hospitals located in 43 states and the District of Columbia, serving approximately 114,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials and its community programs, please visit www.davita.com.

SOURCE DaVita Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. DaVita Receives Civil Complaint
2. DaVita Acquires Majority Stake in HomeChoice Partners, Inc.
3. DaVita Teammates Bicycling 230 Miles for Kidney Disease Education
4. DaVita Volunteers Raise More than $1,000,000 for Nationwide Kidney Education and Prevention Programs
5. DaVita Emergency Response Efforts Ensure Vital Treatment for More than 700 Kidney Failure Patients in Need of Life-Saving Dialysis Treatments in Areas Affected by Southern California Wildfires
6. DaVita to Open First Independent Dialysis Clinic in Fargo-Moorhead
7. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
8. DaVita Inc. to Present at JPMorgan Healthcare Conference
9. DaVita and Phoenix-Based Southwest Kidney Institute Form Broad Partnership
10. Nations Leading Dialysis Provider - DaVita - Partners with eDiets(R) to Launch One-of-a-Kind Diet Helper Online Nutrition and Meal Planning Tool for Late-Stage Kidney Disease Patients and Caregivers
11. DaVita Announces Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media ... Pro X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice ... X users can now reveal the media of their split screens with growing ...
(Date:6/26/2016)... (PRWEB) , ... June 27, 2016 , ... Quality metrics ... yet in many ways they remain in the eye of the beholder, according to ... a publication of The American Journal of Managed Care. For the full issue, ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published ... unfamiliar with. The article goes on to state that individuals are now more comfortable ... less common operations such as calf and cheek reduction. The Los Angeles area medical ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: